Improving cardiovascular disease prevention and management in Africa: Issues to consider for the 21st century

Ethnicity and Disease

Volumn 13, Issue 2 SUPPL. 2, 2003, Pages

  Madu, Ernest C ^a   Richardson, Kelly D ^b   Ozigbo, Obinna H ^c   Baugh, Dainia S ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c Royal Albert Hospital   (Nigeria)

^d Nashville Medical Research Institute   (United States)

Author keywords

21st century; Africa; Cardiovascular care; CVD; Disease burden; Epidemiologic transition; Innovations; Noncommunicable diseases; Prevention; Trends

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AFRICA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMIC ASPECT; EPIDEMIC; GOVERNMENT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH STATUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDICAL RESEARCH; PRIMARY PREVENTION; PUBLIC HEALTH; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; COST OF ILLNESS; HEALTH PROMOTION; HEALTH SURVEY;

AFRICA; CARDIOVASCULAR DISEASES; COST OF ILLNESS; HEALTH POLICY; HEALTH PROMOTION; HUMANS; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 0042528359     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Murray CJL, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Mass: Harvard University Press; 1996. Global Burden of Disease and Injury Series, vol 1.
2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
3. Murray CJL, Lopez AD. Regional patterns of disability-free life expectancy and life-adjusted life expectancy: Global Burden of Disease Study. Lancet. 1997;349:1436-1442.
4. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
5. Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997;349:1347-1352.
6. Mathers CD, Sadana R, Salomon JA, Murray CJL, Lopez AD. Health life expectancy in 191 countries, 1999. Lancet. 2001;357:1685-1691.
7. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
8. Reddy KS, Yusef S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596-601.
9. Alberti G. Noncommunicable diseases: tomorrow's pandemics. Bull World Health Organ. 2001;79(10):907.
10. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases. Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001; 104:2855-2864.
11. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. Hypertension in South African adults: results from the Demographic Health Survey, 1998. J Hypertens. 2001;19: 1717-1725.
12. Cooper RS, Rotimi C. Establishing the epidemiologic basis for prevention of cardiovascular disease in Africa. Ethn Dis. 1993;3:S13-S23.
13. Vorster HH. The emergence of cardiovascular disease during urbanization of Africans. Public Health Nutr. 2002;5(1A):239-243.
14. Sen K, Bonita R. Global health status: two steps forward, one step back. Lancet. 2000; 356:577-582.
15. Unwin N, Mugusi F, Aspray T, Whiting D, et al. Tackling the emerging pandemic of noncommunicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health. 1999;113:141-146.
16. Bulatao RA. Mortality by cause, 1970 to 2015. In: Gribble A, Preston S, eds. The Epidemiological Transition. Washington, DC: National Academy of Sciences Press; 1993: 42-68.
17. Omran AR. The epidemiologic transformation: a theory of the epidemiology of population change. Milbank Memorial Fund Q. 1971;49:509-538.
18. Unwin N, Setel P, Rashi S, et al. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ. 2001; 79(10):947-995.
19. Howson CP, Reddy KS, Ryan TJ, Bale JR, eds. Control of cardiovascular disease in developing countries: research, development, and institutional strengthening [online book]. Washington, DC: National Academy Press; 1998;16-22, 39-42. Available at: http://books.nap.edu/books/0309061377/html/R13.html. Accessed December 31, 2002.
20. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends in coronary heart disease, stroke, and other cardiovascular disease in the United States. Findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000;102:3137-3147.
21. Nissinen A, Berrios X, Puska P. Community-based noncommunicable disease interventions: lessons learned from developed countries for developing ones. Bull World Health Organ. 2001;79(10):963-970.
22. Seedat YK. Hypertension in developing nations in sub-Saharan Africa. J Hum Hypertens. 2000;94:739-747.
23. Chapman S. Recent advances: tobacco control. BMJ. 1996;313:97-100.
24. World Health Organization. Attacking the attacker: WHO steps up its fight against rheumatic fever. WHO Press Releases. December 3, 1999;73.
25. Hutt MSR. Cancer and cardiovascular diseases. In: RG Feachem, Jamison DT, eds. Disease and Mortality in Sub-Saharan Africa. New York, NY: Oxford University Press for the World Bank; 1991:221-240.
26. MacLean DR, Chockalingham A. Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Disease: the role of the cardiovascular specialist. Available at: http://www.ccs.ca/society/conferences/archives/1998/1998coneng-06.cfm. Accessed December 31, 2002.
27. Cooper RS, Rotimi CN, Kaufman JS, Muna WFT, Mensah GA. Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy. BMJ. 1998;316: 614-617.
28. Edwards R, Unwin B, Mugasi F, Whiting D, et al. Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens. 2000;18:145-152.
29. World Health Organization. Noncommunicable diseases. WHO experts warn against inadequate prevention, particularly in developing countries. Fact Sheet N 106. March 1996. Available at: http://www.who.int/inf-fs/en/fact106.html. Accessed January 5, 2003.
30. Muna WFT. The importance of cardiovascular research in Africa today. Ethn Dis. 1993; 3:S8-S12.
31. Cruickshank JK, Mbanya JC, Wilks R, Balkau B, et al. Hypertension in four African-origin populations: current 'Rule of Halves,' quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens. 2001;19:41-46.
32. Nwosu CM, Nwabueze AC, Ikeh VO. Stroke at the prime of life: a study of Nigerian Africans between the ages of 16 and 45 years. E Afr Med J. 1992;69:384-390.
33. Kahn K, Tollman SM. Stroke in rural South Africa: contributing to the little known about a big problem. S Afr Med J. 1999;89:63-65.
34. Global Analysis Project Team. Political economy of tobacco control in low-income and middle-income countries: lessons from Thailand and Zimbabwe. Bull World Health Organ. 2000;78(7):913-919.
35. Tsai T, ed. Africa's contradiction: Nigeria on the path to democracy. Harv Int Rev. 2002; 24(3):32-35.
36. World Health Organization. Tobacco Free Initiative. Available at: http://www.afro.who.int/tfi/index.html. Accessed January 3, 2003.
37. Ebrahim S, Smith GD. Exporting failure? Coronary heart disease and stroke in developing countries. Int J Epidemiol, 2001;30: 201-205.
38. Ogwell AEO. Tobacco under the microscope. The Tobacco Control Resource Center 2002 [Doctors Manifesto website]. Available at: http://www.doctorsmanifesto.org/manifesto/tax.php. Accessed January 5, 2003.
39. Masironi R, Rothwell K. Trends in and effects of smoking in the world. World Health Stat Q. 1988;41(3-4):228-241.
40. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
41. Adams-Campbell LL, Agurs TD, Ukoli FA. Dietary assessment in Nigerian women: a pilot study. Ethn Dis. 1993;3:S62-S66.
42. Motala AA. Diabetes trends in Africa. Diabetes Metab Res Rev. 2002;18:S14-S20.
43. Proctor M, Moore LL, Singer MR, et al. Risk profiles for noncommunicable diseases in rural and urban schoolchildren in the republic of Cameroon. Ethn Dis. 1996;6:235-243.
44. Tollman SM, Zwi AB. Health system reform and the role of field sites based upon demographic and health surveillance. Bull World Health Organ. 2000;78(1):125-134.
45. Isaakidis P, Swingler GH, Piernaar E, Volmink J, Ioannidis JPA. Relation between burden of disease and randomized evidence in sub-Saharan Africa: survey of research. BMJ. 2002;324:1-5.
46. Abiodun A, Abuja AO. Obasanjo presents N765b budget for 2003. The Guardian. Available at: http://nigeriaworld.com/news/source/2002/nov/headlines/21/26-news.html. Accessed January 4, 2003.
47. Howson CP, Reddy KS, Ryan TJ, Bale JR, eds. Control of cardiovascular disease in developing countries: research, development, and institutional strengthening [online book]. Washington, DC: National Academy Press; 1998:37-38. Available at: http://books.nap.edu/books/0309061377/html/R13.html. Accessed December 31, 2002.
48. Peters DH, Elmendorf AE, Kandola K, Chellaraj G. Benchmarks for health expenditures, services, and outcomes in Africa during the 1990s. Bull World Health Organ. 2000;78(6): 761-769.
49. Castro-Leal F, Dayton J, Demery L, Mehra K. Public spending on health care in Africa: do the poor benefit? Bull World Health Organ. 2001;78(1):66-74.
50. Okoro EO, Adejumo AO, Oyejolo BA. Diabetic care in Nigeria: report of a self-audit. J Diabetes Complications. 2002;16:159-164.
51. Lenfant C. Can we prevent cardiovascular diseases in low- and middle-income countries? Bull World Health Organ. 2001;79:980-987.
52. Steyn K, Bradshaw D, Norman R, Laubscher R, Saloojee Y. Tobacco use in South Africans during 1998: the first demographic and health survey. J Cardiovasc Risk. 2002;9(3): 161-170.
53. Hale LA, Fritz VU, Eales CJ. Do stroke patients realize that a consequence of hypertension is stroke? S Afr Med J. 1998;88:451-454.
54. Pobee JOM. Community-based high blood pressure programs in sub-Saharan Africa. Ethn Dis. 1993;3:S38-S45.